CRISM Therapeutics Corporation (AIM:CRTX)
London flag London · Delayed Price · Currency is GBP · Price in GBX
10.75
-0.25 (-2.28%)
Jul 29, 2025, 4:35 PM GMT+1

CRISM Therapeutics Company Description

CRISM Therapeutics Corporation develops a drug delivery technology for the clinical performance of cancer treatments for solid tumors through the local delivery of chemotherapy drugs.

Its lead product is ChemoSeed, an implantable biodegradable drug delivery technology for the delivery of chemotherapy directly into cancer tissues.

The company also offers formulation and consultancy services. The company was formerly known as Amur Minerals Corporation and changed its name to CRISM Therapeutics Corporation in May 2024.

CRISM Therapeutics Corporation was founded in 2016 and is based in Road Town, the British Virgin Islands.

CRISM Therapeutics Corporation
CountryBritish Virgin Islands
Founded2016
IndustryBiotechnology
SectorHealthcare
Employees4
CEOAndrew Webb

Contact Details

Address:
Kingston Chambers
Road Town
British Virgin Islands
Websitecrismtherapeutics.com

Stock Details

Ticker SymbolCRTX
ExchangeLondon Stock Exchange AIM
Fiscal YearJanuary - December
Reporting CurrencyGBP
ISIN NumberVGG042401262
SIC Code1000

Key Executives

NamePosition
Andrew WebbChief Executive Officer
Ae SwansonChief Operating Officer